Cited by 160Bipolar Disorder and TreatmentGlutathione Transferases and PolymorphismsAntioxidant Activity and Oxidative Stress

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.

Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate

Cui, J., Shao, L., Young, L.T., Wang, J.-F.·2007·Neuroscience

DOI 10.1016/j.neuroscience.2006.11.010

Open this paper in CoChat — free account

Abstract

Mood stabilizing drugs lithium and valproate are the most commonly used treatments for bipolar disorder. Previous studies in our laboratory indicate that chronic treatment with lithium and valproate inhibits oxidative damage in primary cultured rat cerebral cortical cells. Glutathione, as the major antioxidant in the brain, plays a key role in defending against oxidative damage. The purpose of this study was to determine the role of glutathione in the neuroprotective effects of lithium and valproate against oxidative damage. We found that chronic treatment with lithium and valproate inhibited reactive oxygen metabolite H(2)O(2)-induced cell death in primary cultured rat cerebral cortical cells, while buthionine sulfoximine, an inhibitor of glutathione rate-limiting synthesis enzyme glutamate-cysteine ligase, reduced the neuroprotective effect of lithium and valproate against H(2)O(2)-induced cell death. Further, we found that chronic treatment with lithium and valproate increased glutathione levels in primary cultured rat cerebral cortical cells and that the effects of lithium and valproate on glutathione levels were dose-dependent in human neuroblastoma SH-SY5Y cells. Chronic treatment with lithium and valproate also increased the expression of glutamate-cysteine ligase in both rat cerebral cortical cells and SH-SY5Y cells. In addition, chronic treatment with other mood stabilizing drugs lamotrigine and carbamazepine, but not antidepressants desipramine and fluoxetine, increased both glutathione levels and the expression of glutamate-cysteine ligase in SH-SY5Y cells. These results suggest that glutathione plays an important role in the neuroprotective effects of lithium and valproate, and that glutathione may be a common target for mood stabilizing drugs.

Integrity signals

Registry

Crossref · 10.1016/j.neuroscience.2006.11.010

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,077
GLUTATHIONE TRANSFERASES
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,565
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Örd, T., & Bredesen, D. E. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671
Biologic and pharmacologic regulation of mammalian glutathione synthesis
Griffith, O. W. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00176-8 · Cited by 1,210
Glutathione S-Transferase Polymorphisms and Their Biological Consequences
Hayes, J. D., & Strange, R. C. (2000) · Pharmacology · doi:10.1159/000028396 · Cited by 997
Frontal lobe and cognitive development
Fuster, J. M. (2002) · Journal of Neurocytology · doi:10.1023/a:1024190429920 · Cited by 916
Glutathione Pathways in the Brain
Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597
Textbook of psychopharmacology
Edwards, G. (1975) · Nature · doi:10.1038/258648b0 · Cited by 583
Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder
Rajkowska, G., Halaris, A. E., & Selemon, L. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01080-0 · Cited by 572

Show all 54 references

Sorted by citations

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594
Self-citation
Impaired mitochondrial function in psychiatric disorders
Manji, H. K., Kato, T., Prospero, N. A. D., Ness, S. L., Beal, M. F., Krams, M., & Chen, G. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3229 · Cited by 493
Mitochondrial Dysfunction and Psychiatric Disorders
Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J., & STRECK, E. L. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9865-8 · Cited by 453
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis
Machado‐Vieira, R., Manji, H. K., & Zarate, C. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00714.x · Cited by 377
Oxidative stress in anxiety and comorbid disorders
Hovatta, I., Juhila, J., & Donner, J. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.08.007 · Cited by 365
Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia
Wang, J., Shao, L., Sun, X., & Young, L. T. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00717.x · Cited by 270
Self-citation
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245
Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
Monti, B., Polazzi, E., & Contestabile, A. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010095 · Cited by 244
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 193
Glutathione: a novel treatment target in psychiatry
Berk, M., Ng, F., Dean, O., Dodd, S., & Bush, A. I. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.001 · Cited by 183
Vitamin D and Depression: Cellular and Regulatory Mechanisms
Berridge, M. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013227 · Cited by 194
Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder
Quiroz, J. A., Gray, N. A., Kato, T., & Manji, H. K. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301671 · Cited by 171
The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence
Zuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157
Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness
Che, Y., Wang, J.-F., Shao, L., & Young, L. T. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090083 · Cited by 155
Self-citation
Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants
Lee, S., Lee, S.-J., Han, C., Patkar, A. A., Masand, P. S., & Pae, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.008 · Cited by 148
The role of hippocampus in the pathophysiology of bipolar disorder
Frey, B. N., Andreazza, A. C., Nery, F. G., Martins, M. R., Quevedo, J., Soares, J. C., & Kapczinski, F. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282df3cde · Cited by 162
The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140
Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment
Xu, Y., Wang, C., Klabnik, J., & Donnell, J. O. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120231448 · Cited by 141
The Neuroprotective Effect of Curcumin and Nigella sativa Oil Against Oxidative Stress in the Pilocarpine Model of Epilepsy: A Comparison with Valproate
Ezz, H. S. A., Khadrawy, Y. A., & Noor, N. A. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0544-9 · Cited by 133
Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: A potential mediator between mitochondria and immune-activation
Kim, H. K., Andreazza, A. C., Elmi, N., Chen, W., & Young, L. T. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.10.015 · Cited by 128
Self-citation
Role of oxidative stress in the pathophysiology of bipolar disorder
Steckert, A. V., Valvassori, S. S., Moretti, M., Dal‐Pizzol, F., & Quevedo, J. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0195-2 · Cited by 126
Is Lithium a Micronutrient? From Biological Activity and Epidemiological Observation to Food Fortification
Szklarska, D., & Rzymski, P. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1455-2 · Cited by 125
Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges
Kim, Y., Santos, R., Gage, F. H., & Marchetto, M. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00030 · Cited by 127
Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione
Das, T. K., Javadzadeh, A., Dey, A., Sabesan, P., Théberge, J., Raduà, J., & Palaniyappan, L. K. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.006 · Cited by 114
Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: Restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β
Correa, F., Mallard, C. E., Nilsson, M., & Sandberg, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.06.016 · Cited by 106
Putative neuroprotective agents in neuropsychiatric disorders
Dodd, S., Maes, M. H. J., Anderson, G., Dean, O. M., Moylan, S., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.007 · Cited by 105
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
“In addition, consistent evidences are showing that the inhibition of oxidative damaging processes provoked by injuries to rat cerebral cortical cells by the chronic treatment with lithium is remarkably efficient [259].”
Background
Molecular neurobiology of bipolar disorder: a disease of ‘mood-stabilizing neurons’?
Kato, T. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.007 · Cited by 103
Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy
Fourcade, S., Ruíz, M., Guilera, C., Hahnen, E., Brichta, L., Naudí, A., Portero‐Otín, M., Dacremont, G., Cartier, N., Wanders, R. J. A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq082 · Cited by 102
The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress
Martinc, B., Grabnar, I., & Vovk, T. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499447 · Cited by 101
Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia
Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., Yatham, L. N., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000617 · Cited by 99
Self-citation
The role of mitochondrial dysfunction in psychiatric disease
Scaglia, F. (2010) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.115 · Cited by 96
Seizure-Induced Oxidative Stress in Status Epilepticus: Is Antioxidant Beneficial?
Lin, T., Chen, S., Lin, K.-J., & Chuang, Y. (2020) · Antioxidants · doi:10.3390/antiox9111029 · Cited by 96
Potential application of lithium in Parkinson's and other neurodegenerative diseases
Lazzara, C. A., & Kim, Y. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00403 · Cited by 98
The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress
Martinc, B., Grabnar, I., & Vovk, T. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143504 · Cited by 95
Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders
STRECK, E. L., Gonçalves, C. L., Furlanetto, C. B., Scaini, G., Dal‐Pizzol, F., & Quevedo, J. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1224 · Cited by 85
Changes in the anti-oxidant system in adult epilepsy patients receiving anti-epileptic drugs
Işık, M., Demir, Y., Kırıcı, M., Demir, R., Şimşek, F., & Beydemir, Ş. (2015) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2015.1026912 · Cited by 81
Effect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion
Kim, K., Li, Y., Jin, G., Chong, W., Liu, B., Lu, J., Lee, K., DeMoya, M. A., Velmahos, G. C., & Alam, H. B. (2011) · Resuscitation · doi:10.1016/j.resuscitation.2011.07.029 · Cited by 81
Decreased global methylation in patients with bipolar disorder who respond to lithium
Huzayyin, A. A. S., Andreazza, A. C., Turecki, G., Cruceanu, C., Rouleau, G. A., Alda, M., & Young, L. T. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001569 · Cited by 80
Self-citation
Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile
Kaddurah-Daouk, R., Yuan, P., Boyle, S. H., Matson, W., Wang, Z., Zeng, Z. B., Zhu, H., Dougherty, G. G., Yao, J. K., Chen, G., et al. (2012) · Scientific Reports · doi:10.1038/srep00667 · Cited by 76
Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder
Scaini, G., Andrews, T., Lima, C. N. D. C., Benevenuto, D., STRECK, E. L., & Quevedo, J. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.12.002 · Cited by 77
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development
Nierenberg, A. A., Kansky, C., Brennan, B. P., Shelton, R. C., Perlis, R. H., & Iosifescu, D. V. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449303 · Cited by 78
Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review
Sher, Y. I., Cramer, A. C. M., Ament, A., Lolak, S., & Maldonado, J. R. (2015) · Psychosomatics · doi:10.1016/j.psym.2015.09.008 · Cited by 76
Chronic lithium treatment magnifies learning in rats
Nocjar, C., Hammonds, M. D., & Shim, S. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.063 · Cited by 74
Parkinson’s Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway
Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2021) · Cells · doi:10.3390/cells10020230 · Cited by 71
Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: Developing treatments using an integrated translational approach
Machado‐Vieira, R., Soeiro‐de‐Souza, M. G., Richards, E. M., Teixeira, A. L., & Zarate, C. A. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.830775 · Cited by 71
Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome
Filosa, S., Pecorelli, A., D’Esposito, M., Valacchi, G., & Hayek, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.019 · Cited by 69
Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF Signaling Pathways.
Kandezi, N., Mohammadi, M., Ghaffari, M., Gholami, M., Motaghinejad, M., & Safari, S. (2020) · PubMed Central · doi:10.22088/ijmcm.bums.9.1.1 · Cited by 67
Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy
Godlewska, B. R., Yip, S. W., Near, J., Goodwin, G. M., & Cowen, P. J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3244-0 · Cited by 67
Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy
Yiş, U., Seçkin, E., Kurul, S. H., Kuralay, F., & Dırık, E. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.02.003 · Cited by 64
The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes
Shao, L., Cui, J., Young, L. T., & Wang, J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.041 · Cited by 63
Self-citation
Oxidative stress in bipolar and schizophrenia patients
Tunçel, Ö. K., Sarísoy, G., Bilgici, B., Pazvantoğlu, O., Çetin, E., Ünverdi, E., Avcı, B., & Böke, Ö. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.04.046 · Cited by 61
Melamine induced cognitive impairment associated with oxidative damage in rat's hippocampus
An, L., Li, Z., Yang, Z. R., & Zhang, T. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.04.009 · Cited by 63
Potential Mechanisms Involved in the Prevention of Neurodegenerative Diseases by Lithium
Camins, A., Verdaguer, E., Junyent, F., Yeste‐Velasco, M., Pelegrı́, C., Vilaplana, J., & Pallàs, M. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00086.x · Cited by 59
Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study
Knorr, U. B., Simonsen, A. H., Roos, P., Weimann, A., Henriksen, T., Christensen, E. M., Vinberg, M., Mikkelsen, R. L., Kirkegaard, T., Jensen, R., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0664-6 · Cited by 57
Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats
Franco, J. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.012 · Cited by 57
Evaluation of Gender-Related Differences in Various Oxidative Stress Enzymes in Mice
Chen, Y., Ji, L., Liu, T., & Wang, Z. (2012) · The Chinese Journal of Physiology · doi:10.4077/cjp.2011.amm080 · Cited by 54
Defects of Mitochondrial Electron Transport Chain in Bipolar Disorder: Implications for Mood-Stabilizing Treatment
Wang, J. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705201202 · Cited by 53
Self-citation
Is lithium neuroprotective? An updated mechanistic illustrated review
Ghanaatfar, F., Ghanaatfar, A., Isapour, P., Farokhi, N., Bozorgniahosseini, S., Javadi, M., Gholami, M., Ulloa, L., Coleman‐Fuller, N., & Motaghinejad, M. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12826 · Cited by 55
Targeting histone deacetylases for the treatment of disease
Lawless, M. W., Norris, S., O'Byrne, K. J., & Gray, S. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00571.x · Cited by 49
Is bipolar disorder a mitochondrial disease?
Young, L. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0715 · Cited by 50
Self-citation
Enhanced Endothelial Cell Senescence by Lithium-induced Matrix Metalloproteinase-1 Expression
Struewing, I. T., Durham, S. N., Barnett, C. D., & Mao, C. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.001735 · Cited by 50
Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain
Valvassori, S. S., Dal-Pont, G. C., Resende, W. R., Jornada, L. K., Peterle, B. R., Machado, A. G., Farias, H. R., de Souza, C. T., Carvalho, A. F., & Quevedo, J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.015 · Cited by 47
Oxidative Stress in Older Patients with Bipolar Disorder
Andreazza, A. C., Gildengers, A. G., Rajji, T. K., Zuzarte, P., Mulsant, B. H., & Young, L. T. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.05.008 · Cited by 47
Self-citation
Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress
Nciri, R., Desmoulin, F., Allagui, M. S., Murat, J., Feki, A. E., Vincent, C., & Croute, F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000132 · Cited by 47
Epigenetic Treatment of Neurological Disease
Gray, S. G. (2011) · Epigenomics · doi:10.2217/epi.11.67 · Cited by 45
Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats
Sharma, S., & Taliyan, R. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1081-2 · Cited by 43
Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats
Safar, M. M., Abdallah, D. M., Arafa, N. M. S., & Abdel-Aziz, M. T. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.076 · Cited by 42
Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells
Schmidt, A. J., Heiser, P., Hemmeter, U. M., Krieg, J.-C., & Vedder, H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.024 · Cited by 40
Targeting Oxidative Stress Component in the Therapeutics of Epilepsy
Azam, F., Prasad, M. V. V., & Thangavel, N. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612800229224 · Cited by 40
Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus‐31 magnetic resonance spectroscopy study
Shi, X., Kondo, D. G., Sung, Y., Hellem, T., Fiedler, K. K., Jeong, E., Huber, R. S., & Renshaw, P. F. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01040.x · Cited by 39
Lithium toxicity and expression of stress-related genes or proteins in A549 cells
Allagui, M. S., Vincent, C., Feki, A. E., Gaubin, Y., & Croute, F. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.04.007 · Cited by 38
Assessing oxidative pathway genes as risk factors for bipolar disorder
Fullerton, J. M., Tiwari, Y., Agahi, G., Heath, A., Berk, M., Mitchell, P. B., & Schofield, P. R. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00834.x · Cited by 37
Long-term Exposure to Low Lithium Concentrations Stimulates Proliferation, Modifies Stress Protein Expression Pattern and Enhances Resistance to Oxidative Stress in SH-SY5Y Cells
Allagui, M. S., Nciri, R., Rouhaud, M. F., Murat, J. C., Feki, A. E., Croute, F., & Vincent, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9804-8 · Cited by 38
Lithium reduces the effects of rotenone-induced complex I dysfunction on DNA methylation and hydroxymethylation in rat cortical primary neurons
Scola, G., Kim, H. K., Young, L. T., Salvador, M. M., & Andreazza, A. C. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3565-7 · Cited by 38
Self-citation
The Relationship between the Number of Manic Episodes and Oxidative Stress Indicators in Bipolar Disorder
Akarsu, S., Bolu, A., Aydemir, E., Zincir, S. B., Kurt, Y. G., Zincir, S., Erdem, M., & Uzun, Ö. (2018) · Psychiatry Investigation · doi:10.30773/pi.2016.12.31 · Cited by 35
Baicalein attenuates proteasome inhibition-induced apoptosis by suppressing the activation of the mitochondrial pathway and the caspase-8- and Bid-dependent pathways
Jung, E. B., & Lee, C. S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.039 · Cited by 35
Targeting Histone Deacetylases for the Treatment of Huntington's Disease
Gray, S. G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00184.x · Cited by 34
Molecular Validation of the Acute Phencyclidine Rat Model for Schizophrenia: Identification of Translational Changes in Energy Metabolism and Neurotransmission
Ernst, A., Ma, D., García‐Pérez, I., Tsang, T. M., Kluge, W. F., Schwarz, E., Guest, P. C., Holmes, E. C., Sarnyai, Z., & Bahn, S. (2012) · Journal of Proteome Research · doi:10.1021/pr300197d · Cited by 35
Lithium for Older Adults with Bipolar Disorder
Shulman, K. I. (2010) · Drugs & Aging · doi:10.2165/11537700-000000000-00000 · Cited by 33
Oxidatively-induced DNA damage and base excision repair in euthymic patients with bipolar disorder
Ceylan, D., Tuna, G., Kırkalı, G., Tunca, Z., Can, G., Arat, H. E., Kant, M., Dizdaroğlu, M., & Özerdem, A. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.03.006 · Cited by 32
Effect of mood stabilizers on gene expression in lymphoblastoid cells
Sugawara, H., Iwamoto, K., Bundo, M., Ishiwata, M., Ueda, J., Kakiuchi, C., Ishigooka, J., & Kato, T. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0340-8 · Cited by 35
Mitochondrial Dysfunction as a Biomarker of Illness State in Bipolar Disorder: A Critical Review
Giménez‐Palomo, A., Gracia, H. A., de Juan, O., Olivier, L., Ochandiano, I., Ilzarbe, L., Valentí, M., Stoppa, A., Llach, C.-D., Pacenza, G., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14121199 · Cited by 34
Potential Role of Glutathione Antioxidant Pathways in the Pathophysiology and Adjunct Treatment of Psychiatric Disorders
Poladian, N., Navasardyan, I., Narinyan, W., Orujyan, D., & Venketaraman, V. (2023) · Clinics and Practice · doi:10.3390/clinpract13040070 · Cited by 35
Targeting Huntington’s disease through histone deacetylases
Gray, S. G. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0025-7 · Cited by 32
Pharmacological evidence for lithium-induced neuroprotection against methamphetamine-induced neurodegeneration via Akt-1/GSK3 and CREB-BDNF signaling pathways.
Mehrafza, S., Kermanshahi, S., Mostafidi, S., Motaghinejad, M., Motevalian, M., & Fatima, S. (2019) · PubMed Central · doi:10.22038/ijbms.2019.30855.7442 · Cited by 31
Effects of acute and chronic quercetin administration on methylphenidate-induced hyperlocomotion and oxidative stress
Kanazawa, L. K. S., Vecchia, D. D., Wendler, E., Hocayen, P. D. A. S., Beirão, P. S. L., de Mélo, M. L., Lívero, F. A. D. R., Corso, C. R., Stipp, M. C., Acco, A., et al. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.01.007 · Cited by 30
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
Khanra, S., Reddy, P. H., Giménez‐Palomo, A., Park, C. H. J., Panizzutti, B., McCallum, M., Arumugham, S. S., Shreekantiah, U., Debnath, M., Das, B., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02134-8 · Cited by 29
Evaluation of glutathione metabolism in NMDA preconditioning against quinolinic acid-induced seizures in mice cerebral cortex and hippocampus
Vandresen-Filho, S., Herculano, B., Franco, J. L., Boeck, C. R., Dafré, A. L., & Tasca, C. I. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.091 · Cited by 26
Mitochondrial dysfunction and lipid peroxidation in rat frontal cortex by chronic NMDA administration can be partially prevented by lithium treatment
Kim, H. K., Isaacs-Trepanier, C., Elmi, N., Rapoport, S. I., & Andreazza, A. C. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.001 · Cited by 26
Vitamin U, a novel free radical scavenger, prevents lens injury in rats administered with valproic acid
Tunalı, S., Kahraman, S., & Yanardağ, R. (2014) · Human & Experimental Toxicology · doi:10.1177/0960327114561665 · Cited by 24
Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays
Mariotti, V., Melissari, E., Amar, S., Conte, A., Belmaker, R. H., Agam, G., & Pellegrini, S. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009225 · Cited by 24
Mitochondrial Dysfunction and Oxidative Stress
Kato, T., Kapczinski, F. P., & Berk, M. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch18 · Cited by 24
α-Lipoic Acid Interaction with Dopamine D2 Receptor-Dependent Activation of the Akt/GSK-3β Signaling Pathway Induced by Antipsychotics: Potential Relevance for the Treatment of Schizophrenia
Deslauriers, J., Desmarais, C., Sarret, P., & Grignon, S. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9884-4 · Cited by 25
Modulation of Hippocampal Antioxidant Defense System in Chronically Stressed Rats by Lithium
Popović, N., Stojiljković, V., Pejić, S., Todorović, A., Pavlović, I., Gavrilović, L., & Pajović, S. B. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8745376 · Cited by 22
The effects of vitamin B6 on lens antioxidant system in valproic acid-administered rats
Tunalı, S. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113506233 · Cited by 22
Chronic treatment with the mood-stabilizing drug lithium up-regulates nuclear factor E2-related factor 2 in rat pheochromocytoma PC12 cells in vitro
Rizak, J. D., Tan, H. T., Zhu, H., & Wang, J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.036 · Cited by 22
Self-citation
GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs
Queiroz, A. I. G., de Araújo, M. M., Araújo, T. D. S., de Souza, G. C., Cavalcante, L. M., Machado, M. D. J. S., de Lucena, D. F., Quevedo, J., & Macêdo, D. S. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9697-6 · Cited by 22

Authors: Cui, J., Shao, L., Young, L. T., & Wang, J.-F.
Affiliations: Centre for Addiction and Mental Health (CA)
Corresponding author: Wang, J.-F.
ORCID: Young, L.T.
Wang, J.-F.
Venue: Neuroscience
Publisher: Elsevier BV
Published: 2007-02
Volume: 144
Issue: 4
Pages: 1447-1453
ISSN: 0306-4522 (ISSN-L)
DOI: 10.1016/j.neuroscience.2006.11.010
OpenAlex: W2085156996
Cited by: 160
References: 54
Citations by year: 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 5 · 2015: 11 · 2014: 13 · 2013: 9 · 2012: 20
FWCI: 7.21
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Keywords: glutathione, neuroprotection, mood stabilizers, lithium, valproic acid, bipolar disorder, oxidative stress, gamma-glutamylcysteine synthetase, buthionine sulfoximine, hydrogen peroxide-induced cell death, SH-SY5Y cells, lamotrigine, carbamazepine, glutathione synthesis
MeSH terms: Lamotrigine, Animals, Brain, Carbamazepine, Cells, Cultured, Cerebral Cortex, Enzyme Inhibitors, Glutamate-Cysteine Ligase, Glutathione, Humans, Lithium, Nerve Degeneration, Neurons, Triazines, Valproic Acid, Cell Death, Rats, Sprague-Dawley, Reactive Oxygen Species, Oxidative Stress, Antimanic Agents, Neuroprotective Agents, Cell Line, Tumor, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks